Supplementary Table S2 from the Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed And/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial
openalex(2023)
关键词
Treatment Outcomes
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要